S&P Futures
3,819.25-8.75(-0.23%)Dow Futures
31,240.00-131.00(-0.42%)Nasdaq Futures
12,784.25-47.50(-0.37%)
Bristol-Myers Squibb Company (BMY)
61.64 -0.46 (-0.74%)
Pre-Market: 6:36AM EST
Chart Events
Performance Outlook
| Previous Close | 62.59 |
| Open | 62.43 |
| Bid | 61.56 x 1100 |
| Ask | 62.49 x 1000 |
| Day's Range | 61.82 - 63.16 |
| 52 Week Range | 45.76 - 67.16 |
| Volume | 14,258,545 |
| Avg. Volume | 11,724,745 |
| Market Cap | 139.134B |
| Beta (5Y Monthly) | 0.62 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.99 |
| Earnings Date | May 05, 2021 - May 10, 2021 |
| Forward Dividend & Yield | 1.96 (3.16%) |
| Ex-Dividend Date | Dec 31, 2020 |
| 1y Target Est | 75.13 |
Fair Value
Related Research
- Business Wire
Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) in Combination with Cabometyx® (cabozantinib) as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma
BMS Receives Positive CHMP Opinion for Opdivo® in Combination with Cabometyx® as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma
- Motley Fool
Here's Why Bristol Myers Squibb Is Making A Mistake With Its Cash
Bristol Myers Squibb (NYSE: BMY) is generating plenty of cash flow and recently used $4 billion of its nest egg to pay down debt. In this video from Motley Fool Live recorded on Feb. 8 (before the transaction was completed), Fool.com contributors Brian Orelli and Keith Speights discuss why that might not be the best use of the pharma company's cash. Brian Orelli: The company plans to retire $4 billion in debt.
- Insider Monkey
Top 15 Pharmaceutical Companies With Highest R&D Spending
In this article we are going to list the top 15 pharmaceutical companies with the highest R&D spending. Click to skip ahead and jump to the Top 5 Pharmaceutical Companies With Highest R&D Spending. Pharma companies have always been among the most important companies in the world, even if they have been much maligned as […]
